Mirae Asset Global Investments’s Larimar Therapeutics LRMR Stock Holding History

Mirae Asset Global Investments’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.2K	Sell	4,646 -1,018	-18%	-$4.04K	﹤0.01%	1528
2026 Q1	$25.5K	Buy	5,664 +1,505	+36%	+$6.01K	﹤0.01%	1402
2025 Q4	$15.8K	Buy	4,159 +850	+26%	+$3.31K	﹤0.01%	1559
2025 Q3	$10.7K	Buy	3,309 +836	+34%	+$3.13K	﹤0.01%	1568
2025 Q2	$7.15K	Buy	2,473 +388	+19%	+$898	﹤0.01%	1524
2025 Q1	$4.9K	Sell	2,085 -41	-2%	-$130	﹤0.01%	1514
2024 Q4	$8.42K	Buy	+2,126	New	+$14K	﹤0.01%	1532

Other funds holding LRMR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

NLP

Next Level Private Harrison, New York $511M AUM 30.94% 1-Year Est. Return

Mirae Asset Global Investments's LRMR Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Larimar Therapeutics (LRMR) stake by 18% in Q2 2026, selling an estimated $4.04K and leaving 4,646 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

Mirae Asset Global Investments first reported a position in LRMR in Q4 2024 and has held it in 7 quarters since. The position peaked at $25.5K in Q1 2026. 46 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

Mirae Asset Global Investments held 4,646 shares of Larimar Therapeutics worth $14.2K as of Q2 2026.
Mirae Asset Global Investments sold 1,018 Larimar Therapeutics shares in Q2 2026, an estimated $4.04K.
Larimar Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1528 holding.
Mirae Asset Global Investments first reported a position in Larimar Therapeutics in Q4 2024 and has held it in 7 quarters since.
Mirae Asset Global Investments's Larimar Therapeutics position peaked at $25.5K in Q1 2026.
46 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.